Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1977 9
1978 15
1979 31
1980 9
1981 22
1982 24
1983 25
1984 25
1985 20
1986 31
1987 37
1988 39
1989 36
1990 44
1991 59
1992 46
1993 44
1994 49
1995 78
1996 130
1997 122
1998 127
1999 107
2000 167
2001 136
2002 183
2003 231
2004 206
2005 231
2006 235
2007 254
2008 238
2009 260
2010 255
2011 307
2012 327
2013 351
2014 337
2015 314
2016 307
2017 297
2018 308
2019 161
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

5,648 results
Results by year
Filters applied: . Clear all
Page 1
Apalutamide for the treatment of prostate cancer.
Rathkopf DE, Scher HI. Rathkopf DE, et al. Expert Rev Anticancer Ther. 2018 Sep;18(9):823-836. doi: 10.1080/14737140.2018.1503954. Expert Rev Anticancer Ther. 2018. PMID: 30101644 Free PMC article. Review.
Darolutamide (ODM-201) for the treatment of prostate cancer.
Shore ND. Shore ND. Expert Opin Pharmacother. 2017 Jun;18(9):945-952. doi: 10.1080/14656566.2017.1329820. Epub 2017 May 24. Expert Opin Pharmacother. 2017. PMID: 28490267 Review.
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies.
Bui MH, Lin X, Albert DH, Li L, Lam LT, Faivre EJ, Warder SE, Huang X, Wilcox D, Donawho CK, Sheppard GS, Wang L, Fidanze S, Pratt JK, Liu D, Hasvold L, Uziel T, Lu X, Kohlhapp F, Fang G, Elmore SW, Rosenberg SH, McDaniel KF, Kati WM, Shen Y. Bui MH, et al. Cancer Res. 2017 Jun 1;77(11):2976-2989. doi: 10.1158/0008-5472.CAN-16-1793. Epub 2017 Apr 17. Cancer Res. 2017. PMID: 28416490 Free article.
Apalutamide: A new agent in the management of prostate cancer.
May MB, Glode AE. May MB, et al. J Oncol Pharm Pract. 2019 Dec;25(8):1968-1978. doi: 10.1177/1078155219864424. Epub 2019 Jul 30. J Oncol Pharm Pract. 2019. PMID: 31359832 Review.
Drug Resistance of Enzalutamide in CRPC.
Chen X, Lu J, Xia L, Li G. Chen X, et al. Curr Drug Targets. 2018;19(6):613-620. doi: 10.2174/1389450118666170417144250. Curr Drug Targets. 2018. PMID: 28413979 Review.
5,648 results
Jump to page
Feedback